Obstructive sleep apnea, oxidative stress, and cardiovascular disease: Evidence from human studies

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Eisele, Hans Joachim ^a   Markart, Philipp ^a   Schulz, Richard ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; BLOOD VESSELS; NITRIC OXIDE; OXIDATIVE STRESS;

CARDIO-VASCULAR DISEASE; CONTINUOUS POSITIVE AIRWAY PRESSURES; ENDOTHELIAL FUNCTION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERMITTENT HYPOXIAS; INTIMA-MEDIA THICKNESS; OBSTRUCTIVE SLEEP APNEA; REACTIVE OXYGEN SPECIES;

SLEEP RESEARCH;

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; REACTIVE OXYGEN METABOLITE; BIOLOGICAL MARKER;

ARTERIAL WALL THICKNESS; BIOAVAILABILITY; BLOOD LEVEL; CARDIOVASCULAR DISEASE; DISEASE MARKER; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; LEUKOCYTE; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN EXPRESSION; REVIEW; SLEEP DISORDERED BREATHING; VASCULARIZATION; CARDIOVASCULAR DISEASES; COMPLICATION; METABOLISM; PATHOLOGY;

BIOMARKERS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84934905550     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/608438     Document Type: Review

References (83)

1. M. Younes, "Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders, " Journal of Applied Physiology, vol. 105, no. 5, pp. 1389-1405, 2008
2. T. Young, P. E. Peppard, and D. J. Gottlieb, "Epidemiology of obstructive sleep apnea: a population health perspective, " American Journal of Respiratory and Critical CareMedicine, vol. 165, no. 9, pp. 1217-1239, 2002
3. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, "The occurrence of sleep-disordered breathing among middleaged adults, "The New Engl and Journal ofMedicine, vol. 328, no. 17, pp. 1230-1235, 1993
4. C. E. Woods, K. Usher, and G. P. Maguire, "Obstructive sleep apnoea in adult indigenous populations in high-income countries: an integrative review, " Sleep and Breathing, vol. 19, no. 1, pp. 45-53, 2015
5. J.M. Marin, S. J. Carrizo, E. Vicente, and A.G.N. Agusti, "Longterm cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study, " The Lancet, vol. 365, no. 9464, pp. 1046-1053, 2005
6. C. E. Sullivan, F. G. Issa, M. Berthon-Jones, and L. Eves, "Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares, " The Lancet, vol. 1, no. 8225, pp. 862-865, 1981
7. R. Dumitrascu, J. Heitmann, W. Seeger, N. Weissmann, and R. Schulz, "Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 234631, 7 pages, 2013
8. O. Marrone and M. R. Bonsignore, "Pulmonary haemodynamics in obstructive sleep apnoea, " Sleep Medicine Reviews, vol. 6, no. 3, pp. 175-193, 2002
9. C. Guilleminault, S. Connolly, and R. Winkle, "Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique, " The Lancet, vol. 1, no. 8369, pp. 126-131, 1984
10. V. A. Rossi, J. R. Stradling, and M. Kohler, "Effects of obstructive sleep apnoea on heart rhythm, " European Respiratory Journal, vol. 41, no. 6, pp. 1439-1451, 2013
11. A. S. Gami, E. J. Olson, W. K. Shen et al., "Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10, 701 adults, " Journal of the American College of Cardiology, vol. 62, no. 7, pp. 610-616, 2013
12. J. Wolf, D. Hering, and K. Narkiewicz, "Non-dipping pattern of hypertension and obstructive sleep apnea syndrome, " Hypertension Research, vol. 33, no. 9, pp. 867-871, 2010
13. A. G. Logan, S. M. Perlikowski, A. Mente et al., "Highprevalence of unrecognized sleep apnoea in drug-resistant hypertension, " Journal of Hypertension, vol. 19, no. 12, pp. 2271-2277, 2001
14. J.-P. Baguet, P. Lvy, G. Barone-Rochette et al., "Masked hypertension in obstructive sleep apnea syndrome, " Journal of Hypertension, vol. 26, no. 5, pp. 885-892, 2008
15. R.H. Mason, G. Ruegg, J. Perkins et al., "Obstructive sleepapnea in patients with abdominal aortic aneurysms: highly prevalent and associated with aneurysm expansion, " American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 5, pp. 668-674, 2011
16. D. Sajkov, T. Wang, N. A. Saunders, A. J. Bune, A. M. Neill, and R. D. McEvoy, "Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease, " American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 5 I, pp. 1518-1526, 1999
17. M. Arzt, R. Luigart, C. Schumet al., "Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism, " European Respiratory Journal, vol. 40, no. 4, pp. 919-924, 2012
18. J. T. Carlson, C. Rangemark, and J. A. Hedner, "Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea, " Journal of Hypertension, vol. 14, no. 5, pp. 577-584, 1996
19. R. Schulz, W. Seeger, C. Fegbeutel et al., "Changes in extracranial arteries in obstructive sleep apnoea, " European Respiratory Journal, vol. 25, no. 1, pp. 69-74, 2005
20. F. Campos-Rodriguez, M. A. Martinez-Garcia, I. de la Cruz-Moron, C. Almeida-Gonzalez, P. Catalan-Serra, and J. M. Montserrat, "Cardiovascularmortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study, " Annals of InternalMedicine, vol. 156, no. 2, pp. 115-122, 2012
21. M.-A. Martiez-Garci, F. Campos-Rodriuez, P. Cataln-Serra et al., "Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study, " American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 9, pp. 909-916, 2012
22. F. P. Cappuccio, D. Cooper, L. D'Elia, P. Strazzullo, and M. A. Miller, "Sleep duration predicts cardiovascular outcomes: a systematic review and meta-Analysis of prospective studies, " European Heart Journal, vol. 32, no. 12, pp. 1484-1492, 2011
23. F. Sofi, F. Cesari, A. Casini, C. Macchi, R. Abbate, and G. F. Gensini, "Insomnia and risk of cardiovascular disease: a metaanalysis, " European Journal of Preventive Cardiology, vol. 21, no. 1, pp. 57-64, 2014
24. M. A. Gupta and K. Knapp, "Cardiovascular and psychiatric morbidity in Obstructive Sleep Apnea (OSA) with Insomnia (sleep apnea plus) versus obstructive sleep apnea without insomnia: a case-control study from a nationally representative US sample, " PLoS ONE, vol. 9, no. 3, Article ID e90021, 2014
25. V. K. Somers, M. E. Dyken, M. P. Clary, and F. M. Abboud, "Sympathetic neural mechanisms in obstructive sleep apnea, " The Journal of Clinical Investigation, vol. 96, no. 4, pp. 1897-1904, 1995
26. A. K. Htoo, H. Greenberg, S. Tongia et al., "Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation, " Sleep and Breathing, vol. 10, no. 1, pp. 43-50, 2006
27. S. A. Gharib, A. L. Hayes, M. J. Rosen, and S. R. Patel, "A pathway-based analysis on the effects of obstructive sleep apnea in modulating visceral fat transcriptome, " Sleep, vol. 36, no. 1, pp. 23-30, 2013
28. B. G. Phillips, K. Narkiewicz, C. A. Pesek, W. G. Haynes, M. E. Dyken, and V. K. Somers, "Effects of obstructive sleep apnea on endothelin-1 and blood pressure, " Journal of Hypertension, vol. 17, no. 1, pp. 61-66, 1999
29. R. Schulz, C. Hummel, S. Heinemann, W. Seeger, and F. Grimminger, "Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia, " American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 1, pp. 67-70, 2002
30. G. Bokinsky, M. Miller, K. Ault, P. Husb and , and J. Mitchell, "Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation, " Chest, vol. 108, no. 3, pp. 625-630, 1995
31. M. de la Peña, A. Barcel, F. Barbe et al., "Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome, " Respiration, vol. 76, no. 1, pp. 28-32, 2008
32. M. S. M. Ip, B. Lam, M.M. T. Ng, W. K. Lam, K.W. T. Tsang, and K. S. L. Lam, "Obstructive sleep apnea is independently associated with insulin resistance, " American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 670-676, 2002
33. A. M. Adedayo, O. Olafiranye, D. Smith et al., "Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism, " Sleep and Breathing, vol. 18, no. 1, pp. 13-18, 2014
34. H. Sies, "Oxidative stress: a concept in redox biology and medicine, " Redox Biology, vol. 4, pp. 180-183, 2015
35. B. Halliwell, "Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?"TheLancet, vol. 344, no.8924, pp. 721-724, 1994
36. B. Halliwell, "The role of oxygen radicals in human disease, with particular reference to the vascular system, " Haemostasis, vol. 23, no. 1, pp. 118-126, 1993
37. S. Cofta, E. Wysocka, T. Piorunek, M. Rzymkowska, H. Batura-Gabryel, and L. Torlinski, "Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome, " Journal of Physiology and Pharmacology, vol. 59, no. 6, pp. 183-190, 2008
38. K. Katsoulis, T. Kontakiotis, D. Spanogiannis et al., "Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease, " Sleep and Breathing, vol. 15, no. 4, pp. 861-866, 2011
39. C. Pap and reou, "Levels of TBARS are inversely associated with lowest oxygen saturation in obese patients with OSAS, " Sleep and Breathing, vol. 17, no. 4, pp. 1319-1322, 2013
40. A. Svatikova, R. Wolk, L. O. Lerman et al., "Oxidative stress in obstructive sleep apnoea, " European Heart Journal, vol. 26, no. 22, pp. 2435-2439, 2005
41. R. Schulz, S. Mahmoudi, K. Hattar et al., "Enhanced release of superoxide frompolymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy, " American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 2, part 1, pp. 566-570, 2000
42. L. Dyugovskaya, P. Lavie, and L. Lavie, "Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients, " American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 934-939, 2002
43. H.-G. Liu, K. Liu, Y.-N. Zhou, and Y.-J. Xu, "Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population, " Chinese Medical Journal, vol. 122, no. 12, pp. 1369-1374, 2009
44. M. Del Ben, M. Fabiani, L. Loffredo et al., "Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment, " BMC Pulmonary Medicine, vol. 12, article 36, 2012
45. P. J. Andrew and B. Mayer, "Enzymatic function of nitric oxide synthases, " Cardiovascular Research, vol. 43, no. 3, pp. 521-531, 1999
46. J. L. Boucher, C. Moali, and J. P. Tenu, "Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for Larginine utilization, " Cellular and Molecular Life Sciences, vol. 55, no. 8-9, pp. 1015-1028, 1999
47. S. Imai, "Cyclic GMP as a second messenger in the cardiovascular system, " Japanese Heart Journal, vol. 36, no. 2, pp. 127-177, 1995
48. R. A. Cohen, "The role of nitric oxide and other endotheliumderived vasoactive substances in vascular disease, " Progress in Cardiovascular Diseases, vol. 38, no. 2, pp. 105-128, 1995
49. W. H. Koppenol, J. J. Moreno, W. A. Pryor, H. Ischiropoulos, and J. S. Beckman, "Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide, " Chemical Research in Toxicology, vol. 5, no. 6, pp. 834-842, 1992
50. Z. S. Katusic, "Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?" American Journal of Physiology-Heart and Circulatory Physiology, vol. 281, no. 3, pp. H981-H986, 2001
51. F. Arrigoni, B. Ahmetaj, and J. Leiper, "The biology and therapeutic potential of the DDAH/ADMA pathway, " Current Pharmaceutical Design, vol. 16, no. 37, pp. 4089-4102, 2010
52. R. Schulz, D. Schmidt, A. Blum et al., "Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy, " Thorax, vol. 55, no. 12, pp. 1046-1051, 2000
53. M. S. M. Ip, B. Lam, L.-Y. Chan et al., "Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure, " American Journal of Respiratory and Critical CareMedicine, vol. 162, no. 6, pp. 2166-2171, 2000
54. A. Alonso-Fernndez, F. Garc-R, M. A. Arias et al., "Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a r and omised trial, " Thorax, vol. 64, no. 7, pp. 581-586, 2009
55. Y. Ozkan, H. Firat, B. Smsk, M. Torun, and S. Yardim-Akaydin, "Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS), " Sleep and Breathing, vol. 12, no. 2, pp. 149-154, 2008
56. A. Barcel, M. de la Peña, O. Aylln et al., "Increased plasma levels of asymmetric dimethylarginine and soluble CD40 lig and in patients with sleep apnea, " Respiration, vol. 77, no. 1, pp. 85-90, 2009
57. M. Yksel, H. K. Okur, Z. Pelin, A. V. Gncand L. Oztrk, "Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome, " Clinics, vol. 69, no. 4, pp. 247-252, 2014
58. A. Barcel, C. Miralles, F. Barb, M. Vila, S. Pons, and A. G. N. Agust "Abnormal lipid peroxidation in patients with sleep apnoea, " European Respiratory Journal, vol. 16, no. 4, pp. 644-647, 2000
59. L. Lavie, A. Vishnevsky, and P. Lavie, "Evidence for lipid peroxidation in obstructive sleep apnea, " Sleep, vol. 27, no. 1, pp. 123-128, 2004
60. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, "8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy, " Chest, vol. 124, no. 4, pp. 1386-1392, 2003
61. G. L. Milne, Q. Dai, and L. J. Roberts II, "The isoprostanes-25 years later, " Biochimica et Biophysica Acta, vol. 1851, no. 4, pp. 433-445, 2015
62. S. Ozben, N. Huseyinoglu, F. Hanikoglu et al., "Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea, " European Journal of Clinical Investigation, vol. 44, no. 11, pp. 1045-1052, 2014
63. E. Hopps, B. Canino, V. Cal and rino, M. Montana, R. Lo Presti, and G. Caimi, "Lipid peroxidation and protein oxidation are related to the severity of OSAS, " European Review for Medical and Pharmacological Sciences, vol. 18, no. 24, pp. 3773-3778, 2014
64. M. Yamauchi, H. Nakano, J. Maekawa et al., "Oxidative stress in obstructive sleep apnea, " Chest, vol. 127, no. 5, pp. 1674-1679, 2005
65. J. Xie, J. Jiang, K. Shi et al., "DNA damage in peripheral blood lymphocytes from patients with OSAHS, " Sleep and Breathing, vol. 18, no. 4, pp. 775-780, 2014
66. Y. S. Kim, J. W. Kwak, K. E. Lee et al., "Can mitochondrial dysfunction be a predictive factor for oxidative stress in patients with obstructive sleep apnea?" Antioxidants & Redox Signaling, vol. 21, no. 9, pp. 1285-1288, 2014
67. K. Christou, A. N. Moulas, C. Pastaka, and K. I. Gourgoulianis, "Antioxidant capacity in obstructive sleep apnea patients, " Sleep Medicine, vol. 4, no. 3, pp. 225-228, 2003
68. A. Barcel, F. Barb, M. de la Peña et al., "Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment, " European Respiratory Journal, vol. 27, no. 4, pp. 756-760, 2006
69. P. Faure, R. Tamisier, J.-P. Baguet et al., "Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome, " European Respiratory Journal, vol. 31, no. 5, pp. 1046-1053, 2008
70. E. Wysocka, S. Cofta, M. Cymerys, J. Gozdzik, L. Torlinski, and H. Batura-Gabryel, "The impact of the sleep apnea syndrome on oxidant-Antioxidant balance in the blood of overweight and obese patients, " Journal of Physiology and Pharmacology, vol. 59, supplement 6, pp. 761-769, 2008
71. M. S. Hoffmann, P. Singh, R. Wolk, A. Romero-Corral, S. Raghavakaimal, and V. K. Somers, "Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea, " Antioxidants and Redox Signaling, vol. 9, no. 6, pp. 661-669, 2007
72. S. Jelic, M. Padeletti, S. M. Kawut et al., "Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea, " Circulation, vol. 117, no. 17, pp. 2270-2278, 2008
73. B. T. Patt, D. Jarjoura, D. N. Haddad et al., "Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea, " The American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1540-1545, 2010
74. S. Varadharaj, K. Porter, A. Pleister et al., "Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction, " Respiratory Physiology & Neurobiology, vol. 207, pp. 40-47, 2015
75. M. S. M. Ip, H.-F. Tse, B. Lam, K. W. T. Tsang, and W.-K. Lam, "Endothelial function in obstructive sleep apnea and response to treatment, " American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 3, pp. 348-353, 2004
76. Y. Ohike, K. Kozaki, K. Iijima et al., "Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure: possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine, " Circulation Journal, vol. 69, no. 2, pp. 221-226, 2005
77. L. Loffredo, A. M. Zicari, F. Occasi et al., "Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role ofNADPHoxidase, " Atherosclerosis, vol. 240, no. 1, pp. 222-227, 2015
78. D. Monneret, J.-L. Pepin, D. Godin-Ribuot et al., "Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients, " Free Radical Biology and Medicine, vol. 48, no. 4, pp. 619-625, 2010
79. M. Grebe, H. J. Eisele, N. Weissmann et al., "Antioxidant vitamin C improves endothelial function in obstructive sleep apnea, " American Journal of Respiratory and Critical CareMedicine, vol. 173, no. 8, pp. 897-901, 2006
80. N. J. Bchner, I. Quack, M. Woznowski, C. Sthle, U. Wenzel, and L. C. Rump, "Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy, " Respiration, vol. 82, no. 5, pp. 409-417, 2011
81. A. A. El Solh, R. Saliba, T. Bosinski, B. J. B. Grant, E. Berbary, and N. Miller, "Allopurinol improves endothelial function in sleep apnoea: a r and omised controlled study, " European Respiratory Journal, vol. 27, no. 5, pp. 997-1002, 2006
82. R. Schulz, G. Murzabekova, B. Egemnazarov et al., "Arterial hypertension in amurinemodel of sleep apnea: role of NADPH oxidase 2, " Journal of Hypertension, vol. 32, no. 2, pp. 300-305, 2014
83. N. R. Prabhakar, G. K. Kumar, and Y.-J. Peng, "Sympathoadrenal activation by chronic intermittent hypoxia, " Journal of Applied Physiology, vol. 113, no. 8, pp. 1304-1310, 2012